Amid all the new high-tech therapies on display at the ESMO cancer conference ... compared to CRT alone. After five years of follow-up, 80% of women who received the more intensive treatment ...

The largest ever clinical trial of T cell therapy (a type of cell-based immunotherapy) for solid tumours has been completed. Led by a Singapore clinician-investigator, the global, international, ...

The largest ever clinical trial of T cell therapy for solid tumours has ended, heralding a new era for precision T cell ...

The suspect, Daniel Schmidt, was restrained by several members of the public. A 24-year-old Illinois man has been arrested after allegedly causing a disturbance in a voting line before punching an ...

Operator Good morning and good afternoon, and welcome to the Novartis Q3 2024 results release conference call and live ...

This Industry Satellite Symposium was presented at the European Society for Medical Oncology (ESMO) Congress 2024, held in ...

Total Worldwide Sales Were $16.7 Billion, an Increase of 4% From Third Quarter 2023; Excluding the Impact of Foreign Exchange ...

November 6, 2024Personalis, Inc. misses on earnings expectations. Reported EPS is $-0.64 EPS, expectations were $-0.33. Operator: Good afternoon, everyone, and welcome to Personalis Third Quarter 2024 ...

And now, 24 years later, the walls of the first two stores are finally going up. Construction has started on Sprouts and Target. Low gray walls are up at what will be Sprouts, closest to Clovis ...

Regulatory News: Median Technologies (ALMDT:PA) announced today that the Company will be participating in the prestigious 2023 European Society for Medical Oncology (ESMO) Congress, set to take ...

Greetings, and welcome to the Incyte third-quarter financial results conference call and webcast. (Operator Instructions) As a reminder, this conference is being recorded. It's now my pleasure to turn ...